DrugPatentWatch Database Preview

Teva Parenteral Company Profile

« Back to Dashboard

What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?

TEVA PARENTERAL has forty-seven approved drugs.

There are six tentative approvals on TEVA PARENTERAL drugs.

Summary for Teva Parenteral

US Patents:	0
Tradenames:	39
Ingredients:	37
NDAs:	47
Patent Litigation for Teva Parenteral:	See patent lawsuits for Teva Parenteral

Drugs and US Patents for Teva Parenteral

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Parenteral	CARBOPLATIN	carboplatin	INJECTABLE;IV (INFUSION)	077389-003	Mar 30, 2007		DISCN	No	No
Teva Parenteral	IDARUBICIN HYDROCHLORIDE	idarubicin hydrochloride	INJECTABLE;INJECTION	065037-002	May 1, 2002		DISCN	No	No
Teva Parenteral	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	072999-001	Oct 23, 1991		DISCN	No	No
Teva Parenteral	NEOSAR	cyclophosphamide	INJECTABLE;INJECTION	040015-004	Apr 29, 1993		DISCN	No	No

Expired US Patents for Teva Parenteral

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-001	Approved Prior to Jan 1, 1982	3,444,294
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-002	Approved Prior to Jan 1, 1982	3,444,294

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Teva
• Teva Branded Pharm
• Teva Parenteral
• Teva Pharm